Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Re: international phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.
Wood DP.
J Urol. 2012 Feb;187(2):473. Epub 2011 Dec 16. No abstract available.
Related citations
Re: bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
J Urol. 2012 Feb;187(2):473-4. Epub 2011 Dec 16. No abstract available.
A novel therapeutic vaccine of mouse GM-CSF surface modified MB49 cells against metastatic bladder cancer.
Zhang X, Shi X, Li J, Hu Z, Zhou D, Gao J, Tan W.
J Urol. 2012 Mar;187(3):1071-9. Epub 2012 Jan 21.
Long-term impact of arsenic in drinking water on bladder cancer health care and mortality rates 20 years after end of exposure.
Fernández MI, López JF, Vivaldi B, Coz F.
J Urol. 2012 Mar;187(3):856-61. Epub 2012 Jan 15.
Use of fluorescence in situ hybridization to predict response to bacillus Calmette-Guérin therapy for bladder cancer: results of a prospective trial.
Kamat AM, Dickstein RJ, Messetti F, Anderson R, Pretzsch SM, Gonzalez GN, Katz RL, Khanna A, Zaidi T, Wu X, Grossman HB, Dinney CP.
J Urol. 2012 Mar;187(3):862-7. Epub 2012 Jan 15.
Re: Effect of mitomycin C on concentrations of vascular endothelial growth factor and its receptors in bladder cancer cells and in bladders of rats intravesically instilled with mitomycin C.
J Urol. 2012 Jan;187(1):352-3. No abstract available.
Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility.
Salinas-Sánchez AS, Donate-Moreno MJ, López-Garrido MP, Giménez-Bachs JM, Escribano J.
J Urol. 2012 Feb;187(2):700-6. Epub 2011 Dec 16.
Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer.
Eswara JR, Efstathiou JA, Heney NM, Paly J, Kaufman DS, McDougal WS, McGovern F, Shipley WU.
J Urol. 2012 Feb;187(2):463-8. Epub 2011 Dec 15.
Intravesical bacillus Calmette-Guérin outcomes in patients with bladder cancer and asymptomatic bacteriuria.
Herr HW.
J Urol. 2012 Feb;187(2):435-7. Epub 2011 Dec 15.
Anti-angiogenic effects of the superantigen staphylococcal enterotoxin B and bacillus Calmette-Guérin immunotherapy for nonmuscle invasive bladder cancer.
Reis LO, Ferreira U, Billis A, Cagnon VH, Fávaro WJ.
J Urol. 2012 Feb;187(2):438-45. Epub 2011 Dec 15.
Standard lymph node dissection for bladder cancer: significant variability in the number of reported lymph nodes.
Meijer RP, Nunnink CJ, Wassenaar AE, Bex A, van der Poel HG, van Rhijn BW, Meinhardt W, Horenblas S.
J Urol. 2012 Feb;187(2):446-50. Epub 2011 Dec 15. Erratum in: J Urol. 2012 Apr;187(4):1513. Meijer, R P P [corrected to Meijer, R P].
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers.
Shariat SF, Chromecki TF, Cha EK, Karakiewicz PI, Sun M, Fradet Y, Isbarn H, Scherr DS, Bastian PJ, Pummer K, Fajkovic H, Sagalowsky AI, Ashfaq R, Doblinger M, Cote RJ, Lotan Y.
J Urol. 2012 Feb;187(2):457-62. Epub 2011 Dec 15.
Using gene polymorphisms to assess bladder cancer risk: progress and challenges.
Kiltie AE.
J Urol. 2012 Feb;187(2):379-80. Epub 2011 Dec 15. No abstract available.
Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro.
Deb AA, Wilson SS, Rove KO, Kumar B, Koul S, Lim DD, Meacham RB, Koul HK.
J Urol. 2011 Dec;186(6):2426-33. Epub 2011 Oct 21.
Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors.
Pellucchi F, Freschi M, Ibrahim B, Rocchini L, Maccagnano C, Briganti A, Rigatti P, Montorsi F, Colombo R.
J Urol. 2011 Dec;186(6):2194-9. Epub 2011 Oct 22.
Editorial comment.
Montironi R.
J Urol. 2011 Dec;186(6):2199-200. Epub 2011 Oct 22. No abstract available.
The FGFR3 mutation is related to favorable pT1 bladder cancer.
van Rhijn BW, van der Kwast TH, Liu L, Fleshner NE, Bostrom PJ, Vis AN, Alkhateeb SS, Bangma CH, Jewett MA, Zwarthoff EC, Zlotta AR, Bapat B.
J Urol. 2012 Jan;187(1):310-4. Epub 2011 Nov 17.
Influence of renal excretory function on the performance of urine based markers to detect bladder cancer.
Todenhöfer T, Hennenlotter J, Witstruk M, Gakis G, Aufderklamm S, Kuehs U, Stenzl A, Schwentner C.
J Urol. 2012 Jan;187(1):68-73. Epub 2011 Nov 16.
Error occurred: cannot get document summary
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on